KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97

ABSTRACTCeftazidime-avibactam (CZA) therapy has significantly improved survival rates for patients infected by carbapenem-resistant bacteria, including KPC producers. However, resistance to CZA is a growing concern, attributed to multiple mechanisms. In this study, we characterized four clinical CZA...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	María Belén Sanz, Fernando Pasteran, Juan Manuel de Mendieta, Florencia Brunetti, Ezequiel Albornoz, Melina Rapoport, Celeste Lucero, Laura Errecalde, Maria Rosa Nuñez, Renata Monge, Magdalena Pennini, Pablo Power, Alejandra Corso, Sonia A. Gomez
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology 2024-03-01
Saila:	Microbiology Spectrum
Gaiak:	ceftazidime/avibactam KPC Klebsiella pneumoniae allelic variant
Sarrera elektronikoa:	https://journals.asm.org/doi/10.1128/spectrum.04111-23
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!